New prospects and strategies for drug target discovery in neurodegenerative disorders
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical)
Link
http://www.springerlink.com/index/pdf/10.1602/neurorx.2.4.627
Reference68 articles.
1. Winblad B, Ljunggren G, Karlsson G, Wimo A. What are the costs to society and to individuals regarding diagnostic procedures and care of patients with dementia? Acta Neurol Scand Suppl 168: 101–104, 1996.
2. Glenner GG, Wong CW. Alzheimer’s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120: 885–890, 1984.
3. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297: 353–356, 2002.
4. Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature 349: 704–706, 1991.
5. Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH, et al. Candidate gene for the chromosome 1 familial Alzheimer’s disease locus. Science 269: 973–977, 1995.
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mitochondrial dysfunctions, oxidative stress and neuroinflammation as therapeutic targets for neurodegenerative diseases: An update on current advances and impediments;Neuroscience & Biobehavioral Reviews;2023-01
2. Cell models for Alzheimer’s and Parkinson’s disease: At the interface of biology and drug discovery;Biomedicine & Pharmacotherapy;2022-05
3. A Review on Chitosan in Drug Delivery for Treatment of Neurological and Psychiatric Disorders;Current Pharmaceutical Biotechnology;2022-03
4. Gauging the role and impact of drug interactions and repurposing in neurodegenerative disorders;Current Research in Pharmacology and Drug Discovery;2021
5. Perspective insights of repurposing the pleiotropic efficacy of statins in neurodegenerative disorders: An expository appraisal;Current Research in Pharmacology and Drug Discovery;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3